Clinical Trial

Efficacy and Safety Study of 610 in Patients With Severe Asthma

Name: Efficacy and Safety Study of 610 in Patients With Severe Asthma — clinical trial record (NCT06323213)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The primary objective of the study is to evaluate the efficacy and safety of 610 in Chinese adults with severe asthma.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-03-14.

Status change: Not Yet Recruiting → Recruiting 2026-01-04

Trial Details

NCT Number	NCT06323213
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Asthma
Enrollment	480 participants
Start Date	2024-06-24
Primary Completion	2027-02 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-01-07